Compassionate Use of Vorinostat for the Treatment of Patients With Advanced Cutaneous T-Cell Lymphoma (0683-042)
Condition(s):Lymphoma, T-Cell, CutaneousLast Updated:September 22, 2022No longer available
Hide Studies Not Open or Pending
Condition(s):Lymphoma, T-Cell, CutaneousLast Updated:September 22, 2022No longer available
Condition(s):Lymphoma, T-Cell, PeripheralLast Updated:March 18, 2020Completed
Condition(s):Lymphoma, T-Cell, Peripheral; Lymphoma, T-Cell, CutaneousLast Updated:January 13, 2020Completed
Condition(s):T-cell Non-Hodgkin LymphomaLast Updated:January 30, 2023Terminated
Condition(s):Lymphoma, T-Cell, PeripheralLast Updated:July 8, 2022Terminated
Condition(s):Peripheral T Cell LymphomaLast Updated:January 18, 2017Unknown status
Condition(s):Peripheral T-cell LymphomaLast Updated:June 12, 2018Unknown status
Condition(s):T Cell LymphomaLast Updated:August 13, 2020Completed
Condition(s):Peripheral T Cell LymphomaLast Updated:July 7, 2023Not yet recruiting
Condition(s):Lymphoma, T-Cell, CutaneousLast Updated:February 12, 2009Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.